Kwon M, Park H, Lim H, Son I, Kim M, Kim N
Int J Mol Sci. 2024; 25(2).
PMID: 38256174
PMC: 10816845.
DOI: 10.3390/ijms25021103.
Xu R, Wang Q, Zhu J, Bei Y, Chu Y, Sun Z
Bioeng Transl Med. 2023; 8(6):e10585.
PMID: 38023696
PMC: 10658479.
DOI: 10.1002/btm2.10585.
Fan X, Huang Y, Zhong Y, Yan Y, Li J, Fan Y
World J Surg Oncol. 2023; 21(1):250.
PMID: 37592311
PMC: 10433616.
DOI: 10.1186/s12957-023-03066-x.
Wang H, Liu G, Jin X, Song S, Chen S, Zhou P
J Cancer. 2022; 13(7):2126-2137.
PMID: 35517410
PMC: 9066214.
DOI: 10.7150/jca.69375.
Anderson P, Aptsiauri N, Ruiz-Cabello F, Garrido F
Cell Mol Immunol. 2021; 18(3):556-565.
PMID: 33473191
PMC: 8027055.
DOI: 10.1038/s41423-021-00634-7.
The impact of host immune cells on the development of neurofibromatosis type 1: The abnormal immune system provides an immune microenvironment for tumorigenesis.
Wei C, Gu S, Ren J, Gu Y, Xu X, Chou X
Neurooncol Adv. 2020; 1(1):vdz037.
PMID: 32642666
PMC: 7212924.
DOI: 10.1093/noajnl/vdz037.
Cancer immune escape: MHC expression in primary tumours versus metastases.
Garrido F, Aptsiauri N
Immunology. 2019; 158(4):255-266.
PMID: 31509607
PMC: 6856929.
DOI: 10.1111/imm.13114.
The evolving understanding of immunoediting and the clinical impact of immune escape.
McCoach C, Bivona T
J Thorac Dis. 2018; 10(3):1248-1252.
PMID: 29708132
PMC: 5906217.
DOI: 10.21037/jtd.2018.03.60.
The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue Architecture.
Garrido F, Perea F, Bernal M, Sanchez-Palencia A, Aptsiauri N, Ruiz-Cabello F
Vaccines (Basel). 2017; 5(1).
PMID: 28264447
PMC: 5371743.
DOI: 10.3390/vaccines5010007.
Rejection versus escape: the tumor MHC dilemma.
Garrido F, Ruiz-Cabello F, Aptsiauri N
Cancer Immunol Immunother. 2017; 66(2):259-271.
PMID: 28040849
PMC: 11028748.
DOI: 10.1007/s00262-016-1947-x.
Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity.
Phua K, Staats H, Leong K, Nair S
Sci Rep. 2014; 4:5128.
PMID: 24894817
PMC: 4044635.
DOI: 10.1038/srep05128.
Role of the HLA System in the Pathogenesis of Dupuytren's Disease.
McCarty S, Syed F, Bayat A
Hand (N Y). 2011; 5(3):241-50.
PMID: 21886544
PMC: 2920393.
DOI: 10.1007/s11552-009-9255-y.
Anti-angiogenesis immunotherapy.
Schoenfeld J, Dranoff G
Hum Vaccin. 2011; 7(9):976-81.
PMID: 21860259
PMC: 3225770.
DOI: 10.4161/hv.7.9.16407.
IRF-1 and p65 mediate upregulation of constitutive HLA-A antigen expression by hepatocellular carcinoma cells.
Shen Y, Xia M, Zhang J, Xu L, Yang J, Chen A
Mol Immunol. 2009; 46(10):2045-53.
PMID: 19428110
PMC: 3426235.
DOI: 10.1016/j.molimm.2009.03.001.
Nodal microinvolvement in patients with carcinoma of the papilla of vater receiving no adjuvant chemotherapy.
Bogoevski D, Chayeb H, Cataldegirmen G, Schurr P, Kaifi J, Mann O
J Gastrointest Surg. 2008; 12(11):1830-7.
PMID: 18791769
DOI: 10.1007/s11605-008-0683-8.
HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer.
Kikuchi E, Yamazaki K, Torigoe T, Cho Y, Miyamoto M, Oizumi S
Cancer Sci. 2007; 98(9):1424-30.
PMID: 17645781
PMC: 11159758.
DOI: 10.1111/j.1349-7006.2007.00558.x.
MHC class I and class II molecules are expressed in both human and mouse prostate tumor microenvironment.
Nanda N, Birch L, Greenberg N, Prins G
Prostate. 2006; 66(12):1275-84.
PMID: 16741922
PMC: 2276872.
DOI: 10.1002/pros.20432.
Prediction of lymph node metastasis by analysis of gene expression profiles in primary lung adenocarcinomas.
Xi L, Lyons-Weiler J, Coello M, Huang X, Gooding W, Luketich J
Clin Cancer Res. 2005; 11(11):4128-35.
PMID: 15930348
PMC: 2211271.
DOI: 10.1158/1078-0432.CCR-04-2525.
Intratumoral immunotherapy: using the tumour against itself.
Crittenden M, Thanarajasingam U, Vile R, Gough M
Immunology. 2004; 114(1):11-22.
PMID: 15606790
PMC: 1782057.
DOI: 10.1111/j.1365-2567.2004.02001.x.
Loss of CDX1 expression in colorectal carcinoma: promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell lines.
Wong N, Britton M, Choi G, Stanton T, Bicknell D, Wilding J
Proc Natl Acad Sci U S A. 2004; 101(2):574-9.
PMID: 14704280
PMC: 327189.
DOI: 10.1073/pnas.0307190101.
